© Copyright Nostre Net
Market Synopsis
The eye
cancer market Share is projected to reach USD 16,955.10 Million by 2030 at
8.60% CAGR during the forecast period 2022-2030. Eye cancer is a common type of
cancer that develops in the eyeball of adults. Cancer is an uncontrolled growth
of the cells, and eye cancer occurs when healthy cells in or around the eye
change and grow uncontrollably, resulting formation of tumors. Different types
of eye cancers are intraocular cancer, squamous cell cancer, rhabdomyosarcoma,
and others. These types of cancer affect eyeball, orbit, and adnexal
structures.
Drivers
The deteriorating lifestyle owing to alcoholism and smoking
is highly instrumental in the rise in the incidence of eye cancer. Lack of
physical activity, regular consumption of unhealthy food items, and increased
stress give rise to possibility of cancer, increasing the eye cancer market
size. In addition, increasing government support for research & development
coupled with rising healthcare expenditure has fueled the market growth to a large
extent.
Restraints
With many treatments available across the globe, there are
high chances that there will be side-effects associated with these procedures.
This factor proves to be highly detrimental to the market growth to some
extent.
However, the market is also buoyed by technological
advancements that could make it easier for patients to seek treatment. For
instance, in August 2018, Google’s DeepMind Health, Moorfields Eye Hospital NHS
Foundation Trust, and University College London (UCL) Institute of
Ophthalmology, in a joint venture created an artificial intelligence (AI) that
accurately dictates how to refer optometry patients in more than 90% of cases.
It is designed to prioritize patients who need to be treated urgently by an eye
care professional.
Market Segmentation
The global eye
cancer market outlook is segmented based on type, treatment and end users.
By type, the market is segmented into intraocular cancer,
squamous cell cancer, rhabdomyosarcoma, and others. Intraocular cancer is
sub-segmented into melanoma of the eye, lymphoma of the eye, and eye cancers in
children.
By treatment, the market is segmented into chemotherapy,
surgery & radiation therapy, targeted therapy, hormone therapy, biologic
therapy, and other. Chemotherapy is sub-segmented into anthracyclines, taxanes,
antimetabolites, and alkylating agents. Target therapy is sub-segmented into
monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is
sub-segmented into selective estrogen-receptor modulators (SERMs), aromatase
inhibitors and others. By end user, the market is segmented into hospital &
clinics, ambulatory care centers, and others.
Regional Outlook
The global eye cancer market is spread across the regions of
the Americas, Europe, Asia Pacific (APAC) and the Middle East & Africa.
Globally, the Americas leads the global eye cancer market on
account of increasing incidences of eye cancer. Moreover, sophisticated
technology, high healthcare expenditure, and strong government support for
research & development have triggered the growth of the eye cancer market
in the region. In addition, presence of market giants in the region supports
the upward trajectory of the market as well.
On the other hand, Europe stands second globally followed by
Asia Pacific. This position was achieved on the back of strong government
support and availability of the funds for research & development.
Sophisticated healthcare infrastructure and strong economic growth in the
region have also been instrumental in the market growth over the past few
years.
MRFR predicts that APAC is growing with the fastest CAGR due
to increasing prevalence of cancer, rapidly developing economy and growing
government support. The Asia Pacific eye cancer market is primarily driven by
Japan, India, and China on account of a massive huge patient pool, and rapidly
developing healthcare sector.
Lastly, the Middle East & Africa claims the least share
of the market owing to limited funding and lack of availability of medical
facilities and poor political conditions. The Middle East has managed to
capture a major share in the Middle East & Africa eye cancer market with
countries such as Kuwait, Qatar, Oman and South Arabia holding a substantial
share. However, the Africa region is deemed to rise at a healthy growth rate
owing to the presence of huge untapped potential for the development of the market.
Key Players
The key players in the global market include Takeda
Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.),
Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.),
GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Amgen, Inc. (U.S.),
Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), AstraZeneca
Plc. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc.
(U.S.), Sanofi (France), AbbVie Inc. (U.S.), Oncomed Pharmaceuticals (U.S.) and
Immunomedics (U.S.).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The Palliative
Care market trends is expected to reach USD 10.815 Billion by 2030 at 7.90%
CAGR during the forecast period 2022-2030. Palliative care is a
multidisciplinary approach focused on providing relief to patients and their
families suffering from terminal illness. Demographic, epidemiological
transitions and changes in lifestyle have raised the incidence of cancer and
other life-threatening or fatal diseases such as cancer, congestive heath
failure, kidney failure, Alzheimer’s and others. In case of such diseases,
control of pain, of other symptoms and psychological, social and emotional
challenges is of paramount importance where palliative care aims to provide the
highest quality of life possible to such patients. Palliative care also extends
to bereavement, if necessary. The global palliative care market is
expected to expand at a CAGR of 8.1% over the forecast period of 2018-2023,
affirms Market Research Future (MRFR) in an in-depth study.
The need for a systematic and comprehensive approach to
cater to all the specific needs at the last stage of a patients’ life has led
to the massive popularity of palliative care, especially in the developed
countries. Various non-profit organizations are initiating towards reducing the
burden of diseases among below-average and average income population which has
further raised demand within the global palliative care market.
Palliative care is gaining widespread acceptance as an
alternative method to curative care by patients who are at the end of their
life. Growing aging population has positively influenced the growth of the market.
Supporting factors include a shift in preference towards non-acute care and the
economic advantages associated with palliative care. Palliative care involves
shifting patients from a high-cost setting to a lower cost setting which
ultimately leads to cost avoidance. Moreover, there is a steep surge in the
awareness regarding the benefits associated with palliative care among the
families of patients which continue to drive the market ahead.
Palliative care has witnessed a dramatic increase in certain
fields such as oncology, and surging prevalence of cancer has been a plus for
the growth of the market. Moreover, oncology disorders among children growing
at an incremental rate have raised the requirement for palliative care as they
are more likely to face disruption in their life.
The recent years have witnessed a significant rise in the
number of palliative care consultation team in hospitals and other healthcare
institutes which triggered growth within the market. The global palliative care
market is expected to find growth opportunities as palliative care is estimated
to penetrate other fields such as neurology, nephrology, and surgery.
On the other hand, the increasing gap between the available
service and identified needs, especially in developing countries are
restricting the growth of the market. Misuse of funding and lack of awareness
are other bottlenecks to market growth.
Segmentation
The global palliative care market has been segmented based
on type, application, and end user.
By type, the global palliative care market has been
segmented into private residence care, hospice inpatient care, hospital
inpatient care, nursing home, and residential facility care and others.
By application, the global palliative care market has been
segmented into cancer, cardiac diseases such as congestive heart failure (CHF),
chronic obstructive pulmonary disease (COPD), kidney failure, Alzheimer’s,
Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and many more.
By end user, the global palliative care market has been
segmented into hospitals, home care settings, palliative care centers,
long-term care centers & rehabilitation centers.
Regional Analysis
By region, the global palliative
care market report has been segmented into the Americas, Europe, Asia
Pacific (APAC), and the Middle East & Africa (MEA).
North America dominates the global palliative care market
due to the high incidence rate of life-threatening diseases in the region. An
increasing number of palliative care facilities in the US coupled with the
availability of funds for R&D development are factors igniting growth
within the North America market.
Europe is the second largest market for palliative care.
Government support increased R&D activities and the growing number of
palliative care centers and aging demographics are driving the growth of the
Europe market.
APAC is expected to showcase a relatively faster growth rate
over the forecast period. An increasing prevalence of chronic diseases, the
rise in geriatric population, and growing awareness regarding palliative care
are expected to stimulate the growth of the APAC market.
The MEA market is likely to showcase sluggish growth due to
lack of knowledge, underdeveloped medical facilities and lack of awareness,
especially in the Africa region.
Competitive Landscape
Kindred Healthcare Incorporated, Gentiva Health Services
Incorporated, Skilled Healthcare Group Incorporated, Amedisys Incorporated,
Sunrise Senior Living LLC, Genesis HealthCare Corporation, Vitas Healthcare
Corporation, and Home Instead Senior Care Incorporated are the key players in
the global palliative care market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Synopsis:
Dental carpule market has witnessed the entry of new
participants, especially local anesthesia manufacturers, over the years, which
is likely to retain the growth of the market. Market Research Future (MRFR) has
revealed in its latest report that Dental Carpule Market is projected to grow
at a substantial CAGR of 5.6% in the upcoming years of the forecast period. The
Dental
Carpule MarkettrendsValue is evaluated to expand up to USD
24 Million in the studied forecast period of 2021-2028. The rising burden
of oral diseases coupled with increasing awareness about oral health care has
fueled the demand for dental carpule passively, and the trend is expected to
continue across the assessment period. Furthermore, the developments introduced
in dental health care are expected to influence dental carpule market growth
positively in the foreseeable future.
The need for safely administering injectable drugs to the
patients having dental problems has catapulted the demand for dental
carpule. However, carpule comes with certain disadvantages, such as the
requirement of force on the plunger, leakage of solution, etc. which might hold
the market growth during the forecast period.
Market Segmentation:
By material, the global dental carpule market has been
segmented into glass, plastic, metal, and others. Among these, the glass
carpule segment accounts for a maximum share of the global market trailed by
the plastic segment.
By end-users, the dental carpule market is segmented into
hospitals, dental clinics, home care, and others.
Regional Analysis:
By region, the global dental
carpule market report has been segmented into North America, Europe,
Asia-Pacific, and, the Middle East and Africa. North America is the largest
market for dental carpule globally. The region is likely to retain its
dominance in the foreseeable future growing at 3.1% CAGR. The market has
entered a maturity phase and is estimated to reach a valuation of USD 9.2 Mn
through the projection period. Increasing awareness about the importance of
safe administration of anesthetics in dental procedures is the driving factor
of growth in North America dental carpule market. Other factors favoring the
expansion of the market are the rapid development of dental industries,
technological advancements, product innovations, etc.
Europe accounts for the second largest share in the dental
carpule market. The dental health care in Europe is much more affordable than
in any other regions, which is expected to catalyze revenue generation for
market participants across the review period. Dental carpule market in Europe
is estimated to thrive at 2.7% CAGR and reach a valuation of USD 3.1 Mn by
2023. Another factor complementing the market growth and expansion in the
region is the increasing demand for dental cosmetics and oral health.
Asia Pacific is an emerging market for dental carpule which
is primarily attributable to the presence of fast-developing economies such as
India, China, etc. The developments in the dental healthcare sector witnessed
in recent times are likely to encourage market proliferation throughout the
assessment period. The Middle East & Africa will exhibit sluggish growth
during the forecast period.
Competitive Dashboard:
Some of the key players profiled by MRFR in its report for a
better understanding of the market are GlaxoSmithKline, Sanofi Genzyme, Merck,
AstraZeneca, Gilead, Roche, Pfizer and Novartis among others. The market is
consolidated with regional, national, and international market operators. The
players strive to retain competitiveness over competitors by employing
strategies such as acquisitions & mergers, expansion of product portfolios,
product developments, technological advancements, etc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Scenario
The Clinical
Intelligence Market share is projected to reach USD 16,753 Million by 2030
at 13.20% CAGR during the forecast period 2022-2030.owing to the increasing
adoption of healthcare IT, asserts Market Research Future (MRFR). Also known as
clinical data analytics, clinical intelligence market is a blend of
technologies which involves the use of data analytics in order to improve the
healthcare delivery. Analysis of clinical data helps to know the loopholes in
an organization’s process that hampers its growth. Clinical intelligence
comprises software for medical records management, Revenue Cycle Management
(RCM), clinical decision support, and financial management and helps to improve
the productivity of an organization, improve patient’s engagement, reduce cost
and time.
Drivers and Constraints Impacting the Market
The global market for clinical intelligence is likely to
grow at a remarkable rate mainly due to the growing adoption of healthcare IT
during the assessment period. With the growing importance of software solutions
in fraud detection and insurance claim processing and increasing use of
electronic health records, the global market for clinical intelligence is set
to boom. Moreover, engagement of software companies in EHR and healthcare IT
influences the market growth at a global pace. The presence of a large number
of market players offering healthcare software solutions is anticipated to
stimulate the market over the review period.
On the flip side, high costs associated with clinical
intelligence software solutions is one of the major factors likely to retard
the market growth in the coming years.
Global Clinical Intelligence Market: Segmental Analysis
The global clinical
intelligence market outlook has been segmented on the basis of components,
type, end-user, application, and region.
By mode of type, the global clinical intelligence market has
been segmented into population health management, retrospective performance
measures & predictive analytics, clinical benchmarking, clinical decision
support (CDSS) system, quality improvement, performance measurement systems,
and others. The quality improvement segment is further sub-segmented into six
sigma. The population health management segment is further sub-segmented into
under-utilization of health services and over-utilization of health services.
By mode of component, the global clinical intelligence
market has been segmented into hardware, software, and services.
By mode of application, the global clinical intelligence
market has been segmented into revenue cycle management (RCM) claims, fraud,
supply chain, financial management, clinical, and others.
By mode of end-users, the global clinical intelligence
market has been segmented into clinics, hospitals, TPAs, and others.
Regional Insights
Geographically, the clinical intelligence market span across
four major regions namely, America, Europe, Asia Pacific, and the Middle East
and Africa.
Among all the regions, America is considered to be the
largest market for clinical intelligence due to extensive use of software
solutions for healthcare administration. North America accounts for the largest
market share in this region due to the presence of healthcare IT companies
namely Allscripts, QSI Management, GE Electric Company, and IBM.
Europe is considered to be the second largest market for
clinical intelligence and is presumed to show a steady growth in the coming
years owing to the technological developments in healthcare IT, growing number
of healthcare providers using clinical management software, patient engagement
platform.
The market for clinical intelligence is anticipated to grow
at a steady pace in the Asia Pacific region due to growing demand for
healthcare IT, increasing number of healthcare software solution providers, and
rising expenditure on healthcare. Moreover, with the rising demand for patient
records management and growing burden of diseases is set to boost the market in
this region during the forecast period.
On the other hand, the Middle East and African region are
also expected to showcase a steady growth due to low demand for healthcare IT
in areas with low healthcare expenditure.
Competitive Dashboard
The major players operating the global market are LLC
(U.S.), QSI Management, Greenway Health, Cerner Corporation (U.S.), McKesson
Corporation (U.S.), Allscripts (U.S.), Epic Systems Corporation (U.S.), IBM
(U.S.), eClinicalWorks (U.S.), General Electric Company (U.S.), and others.
About
US:
Market Research Future (MRFR), enable customers to unravel the complexity of
various industries through Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
Market Highlights
The structural
health monitoring market share is projected to reach USD 4.3 Billion at
CAGR of 15% from 2022 to 2030.The global Structural Health Monitoring market is
projected to record a CAGR of ~15% during the forecast period. Structural Health Monitoring is a type of
monitoring that will detect if there are any damages to the structures.
Structural health monitoring can be applied to many different types of
structures such as buildings, bridges, and pipelines. It can also be used on
other objects such as aircraft and ships.
The COVID-19 outbreak has significantly impacted the global
economy by disrupting production and demand, impacting the supply chain in the
market. The government put a contingency plan in place by putting people inside
their houses with no contact with the outside world. The government imposed a
country-wide lockdown to minimize the risk of any further outbreaks.
There was a decrease in the demand for structural health
monitoring market. During this pandemic, people were focusing on necessary
items and were avoiding the unnecessary costs. This has decreased the demand
for infrastructure projects. Furthermore, the government stopped all
unnecessary activities that have stopped various construction and
infrastructure projects.
Market Research Future has recognized the following
companies as the key players in the global Structural Health Monitoring market
Nova Metrix LLC, Geokon, Campbell Scientific, COWI, Geocomp, Acellent
Technologies, Sixense, Pure Technologies, Structural Monitoring Systems, SGS,
and Digi-Texx among others.
Segmental Analysis
The global structural
health monitoring market outlook has been segmented based on offering,
technology, end-use, and region. By offering, the global structural health
monitoring market has been segmented into hardware, software & services.
The software & services segment is anticipated to witness rapid growth in
the global structural health monitoring market. As soon as the data arrives at
the sensors, the software starts monitoring and analyzing its structure. The
software provides the visual representation of the data on structural behavior
and allows people to see the changes in real-time so that damages can be
detected at the earliest. To do this, structures need to be monitored regularly.
Structural health monitoring is crucial for any project with a large
infrastructure. Structural failures are also increasing frequently, which is
why this technology has become more urgent. To ensure the health and integrity
of various structures and systems, one can use an approach based on the data
collection from sensors installed around the building or machine. These include
parameters related to loading, stress, strain and acceleration. Furthermore, it
can be challenging for structural engineers to process and analyze such high
volumes of data. To get around this, software platforms, apps, and other coding
solutions are being adopted.
By technology, the global structural health monitoring
market has been segmented into wired and wireless. The wired segment is
expected to be the fastest-growing market in the global structural health
monitoring industry. Today, many structures are being monitored with wired
systems. These include bridges, buildings, and dams. The use of wired
structural health monitoring systems has gained traction in the 21st century.
These include the wires, cables, and fibers that enable the acquisition of data
from sensors. It also enables communication with other devices. Wired network
monitoring systems are good for many things including reducing data
attenuation, being high-speed, the system having no limitation on transmission
range, and the network having a high system bandwidth.
Based on the end-use, the global structural health
monitoring market has been segmented based on civil infrastructure, aerospace
& defense, energy, mining, and others. The civil Infrastructure segment is
expected to be the largest revenue generating segment in the global structural
health monitoring market. The civil infrastructure segment includes bridges,
tunnels, dams, buildings & stadiums. Countries have been investing in
physical infrastructure for a long time now. The US, the UK, Japan, Germany,
and other countries have been making increasingly large investments in this
area as they recognize the potential on offer. It is a positive step towards
future economic growth. Rapid urbanization and an urgent need for high-quality
infrastructure are driving the growth of the world civil infrastructure market.
This brings the increasing number of civil infrastructure projects, which are
set to create a high demand for structural health monitoring systems. In other
words, these systems can be used to maintain and monitor the condition of each
structure and avoid catastrophic failures.
Regional Analysis
Geographically, the global structural health monitoring
market has been categorized as North America, Europe, Asia-Pacific, and Rest of
the World. In recent years, the North American market has seen enormous
development in the structural health monitoring sector. Structural health
monitoring has been transforming the way buildings are built and sustained.
Companies have been using this service to detect and prevent structural issues
such as building collapse, fire, or structural failure that can cost thousands
of dollars to repair.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
According to MRFR analysis, the global downstream
processing market trends is expected to register a CAGR of~16.09% from 2021
to 2027and hold a value of ~USD 61,174.53million by 2027.
Downstream processing refers to the series
of operations required to derive pure and homogeneous protein products from
biological materials such as cells, tissue culture fluid, or plant tissues.
There is a high demand for the end products extracted by downstream processing,
owing to the increasing applicationsin biopharmaceutical products. Thus, the downstream
processing market is anticipated to observe significant growth during the
forecast period.
Many market players are dominating the
global downstream processing market. The prominent players are involved in
strategic agreements,new product launches& developments,joint ventures,
partnerships, collaborations, mergers & acquisitions, geographic expansionto
sustaintheir market positions.For instance, in March 2021, Thermo Fisher
Scientific, Inc. (US) announced that more than USD 600 million would be
invested to expand its bioprocessing production capabilities through 2022 to
meet short-term demands related to COVID-19 as well as long-term efforts to
improve new vaccines and biologics for other conditions.
Key Players
Some of the key players in the global
downstream processing market are Thermo Fisher Scientific Inc. (US), Sartorius
Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation
(US), 3M Company (US), Boehringer Ingelheim (Germany), Lonza Group AG
(Switzerland), Eppendorf AG (Switzerland), Corning Incorporated (US), and Asahi
Kasei Corporation (Japan).
Segmentation
The global downstream processing market has
been segmented into technique, product, application, and end user.
By technique, the market has been
segregated into cell disruption, solid-liquid separation,
clarification/concentration, downstream purification techniques, and
formulation. The purification techniques segment is further sub-segmented into
ion exchange, affinity exchange, hydrophobic interaction, size exclusion
chromatography, and others. The purification techniques segment held a
significant share of the market in 2020, as it isone of the vital steps in
downstream processing and has high product differentiation.
Based on the product, the global downstream
processing market has been classified as chromatography columns &resins,
filters, membrane adsorbers, and others. The chromatography columns
&resinsis one of the most widely used product andwasestimated to bethe
largest segment in 2020.
Based on application, the downstream
processing market is segmented into antibiotic production, hormone production,
antibodies production, vaccine production, and others. Antibiotic productionis
one of the vital applications owing to increasing infectious diseases.
Furthermore, the ongoing pandemic has created a huge demand for vaccine
production globally which further supports the growth of the market.
Based on the end user, the downstream
processing market is segmented into biopharmaceutical manufacturers, contract
manufacturing organizations, and others. The biopharmaceutical manufacturers
segment held the largest market share in 2020 due to increased R&D
activities and production of biologics at a largescale, along with the rapidly
growing biopharmaceutical industry.
Regional Analysis
By region, North America is anticipated to
dominate the global downstream
processing market report, owing to well-established research organizations
involved in research activities, the presence of a high number of contract
manufacturing organizations (CMOs), and the presence of a largenumber of
pharmaceutical and biopharmaceutical companies. Moreover, the rise in R&D
investments by public and private players in the healthcare sectorfurther
drives the market growth.
On the other hand, the European downstream
processing market is driven by rising R&D expenditure by biopharmaceutical
companies, increasing investments in the R&D sector, and the presence of
key market players. For instance, in November 2019, Thermo Fisher Scientific,
Inc. (US) announced that it is investing nearly USD 24 million in its Scotland
site to expand global bioproduction capabilities with additional large-volume
liquid manufacturing capacity for cell culture media.
Asia-Pacific is anticipated to be the
fastest-growing market in the region over the assessment period due to growing
and improving healthcare infrastructure, the establishment of research
organizations, and increasing investments in biotechnology. In addition,
factors such as the growing investments by key market players and the rapidly
developing pharma and biopharma sector in the region are further driving the
market.For instance, in April 2021, Asahi Kasei Corporation, a solution
provider to the biologics manufacturing industry, expanded its business in
China with the launch of Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC).The
launch of AKBC facilitates business expansion in China by localizing inventory
management and order processing for shorter delivery times.
Furthermore, the growth of the market in
theRest of the World is attributed to the booming biotechnology sector and
advancements in chromatographic techniques inthe region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Molecular modelling is a strategy that involves
computational techniques that integrates creation, manipulation, and
representation of molecular structures. Based on this technology, a lot of drug
can be developed. This process enables scientists to run various simulations
that can ensure better results for the global drug development market. The
global molecular
modelling market trends is expected to cross USD 1,617.80 million a CAGR of
15.93% during the forecast period 2027. Market Research Future (MRFR) discloses
possibilities that can be explored well in the future to ensure strong growth
in the coming years.
Various factors like hike in research-related investments,
growing impact from pharmaceuticals to discover new drugs, technologies to
develop personalized drug, better healthcare-related investments, growing cases
of chronic disease, hike in budgets for healthcare sector, and other are
expected to influence the global molecular modelling market. The burgeoning
biosimilars and biologics industry is expected to take the market further ahead
in the coming years.
Segmentation:
Product, application, and end-users are segments that have
been included in the global molecular modelling market. This analysis is
expected to provide in-depth analysis of various factors that can be used later
to garner more profits in the coming years.
By product, the molecular modelling market comprises software
and services. The software segment is generating substantial revenue and is
expected to climb up with a 13.55% CAGR. But the services segment is expected
to register the fastest CAGR of 18.64% within the same time frame.
Based on the application, the global molecular modelling
market can be segmented into drug development, drug discovery, and others. the
drug development segment can step ahead with 13.26% CAGR during the forecast
period. The drug discovery segment is deemed to register the fastest CAGR of
17.30% over the assessment period.
By end-users, the molecular modelling market comprises
research centers & academic institutions, pharmaceutical &
biotechnological companies, and others. The pharmaceutical and biotechnological
companies are expected to register a 13.84% growth during the forecast period,
whereas, the research centers and academic institutions can post a CAGR of
19.16% during the review period.
Regional Analysis:
Region-wise analysis of the global molecular
modelling market report has four specific regions under its coverage. These
regions are the Americas, Europe, Asia Pacific (APAC), and the Middle East and
Africa (MEA). The report is all set to provide better demographic analysis to
assist in the exploration of several possibilities that can impact the market
growth in the future.
Technical superiority, robust infrastructure, high
expenditure capacity, better research & development projects, and other
healthcare-related initiatives are expected to provide strong traction to the
regional market. The Americas is a region that includes two regions, North and
South America. North America has better market scenario than South
America.
Europe is sharing similar features like that of North
America. These two regions are known for their research and development
projects where development of new products and innovations are quite expected.
The region is following North America closely in terms of market valuation.
Several countries like the UK, France, Germany, and others are expected to
promote the regional market.
The APAC market is expecting strong growth in the coming
years with assistance from the hike in the market valuation of China, India,
Thailand, Singapore, and others.
Competitive Landscape:
Prominent market players in the global molecular modelling
market are Schrödinger, LLC, Cresset, Acellera Ltd., BioSolve-IT, Optibrium,
Chemical Computing Group, Simulations Plus, Inc., Cambridge Crystallographic
Data Centre OpenEye Scientific Software, Certara, L.P, Dassault Systèmes, and
others. MRFR included these companies and profiled them for a better analysis
of the global process. Such a report also includes various strategic moves
taken by these companies. These moves are merger, acquisition, collaboration,
and other methods.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
According to MRFR analysis, the global biopharmaceutical
excipients market size is expected to register a CAGR of~6.8% from 2021 to
2027 and is expected to hold a value of ~USD 3,114.6 million by 2027
The global biopharmaceutical excipients market is driven by
several factors, such as increasing demand for oral formulations across the
globe, rising demand for customized medicines, and an increasing geriatric
population. Other factors such as increasing patients with chronic
ailmentscoupled with growing life expectancy are driving the production of
biopharmaceuticals. In addition, increasing stress, back pains, body aches, and
headaches has augmented the demand for topical type formulation, accelerating
the market growth.
The industry players focus on expanding their global
footprint by strategic partnerships, investing in some company’s stock,
acquisitions, and product launches. For instance, in February 2020, ReForm
Biologics (US) partnered with MilliporeSigma (US) to commercialize excipients
used in biotherapeutics. In August 2019, LBB Specialties (US) announced the
strategic partnership with MEGGLE (Germany)to expand its excipient distribution
channel across the US. In December 2018, Roquette (France) bought a majority
stake in excipient producer Crest Cellose (India) that enabled the company to
expand its product portfolio and presence in the Indian generic pharmaceutical
market. Furthermore, the prominent players focus on new developments, employee
satisfaction, the transformation of their research wings, and expanding their
distribution network. These factors will augment the market growth and will
increase theproduct demand in the forecast timeline.
Key Players
Some of the key players in the global biopharmaceutical
excipients market are Merck KGaA (Germany), Colorcon (BPSI Holdings Inc) (US),
BASF SE(Germany), Associated British Foods plc (UK), Signet Excipients Pvt. Ltd
(IMCD) (Netherlands), Sigachi Industries Limited (Hyderabad), Spectrum Chemical
Manufacturing Corp. (US), Roquette Frères (France), Clariant (Switzerland), DFE
Pharma (Germany), J. Rettenmaier & Söhne Gmbh + Co Kg (Germany), and Evonik
Industries AG (Germany).
Segmentation
The global biopharmaceutical
excipients market outlook is categorized into product and formulation. Based
on the product category, the market has been segregated into solubilizers &
surfactants/emulsifiers, polyols and carbohydrates, and specialty excipients.
The carbohydrates segment is expected to hold a considerable share of the
market in 2021. Increasing R&D activities for the development of lipid and
protein excipient-based corona vaccines is fueling the market demand. In
addition, the high demand for carbohydrate-based medicines for the infant
segment is propelling the biopharmaceutical excipient market.
Based on formulation, the global biopharmaceutical
excipients market has been classified as oral, topical, and injectables. The
oral segmentheld the major share in 2020 due to the easy intake procedure and
availability of oral medicines throughout the hospitals and retail stores.
Additionally, the demand for oral and topical formulations is accelerating due
to the growing preference for on-the-go treatment and ambulatory treatment
services coupled with increasing cases of trypanophobia.
Regional Analysis
North America is projected to dominate the biopharmaceutical
excipients market due to the growing adoption of the latest drug manufacturing
technologies, increasing chronic diseases, and expansion of production
capabilities of the industry players across the region. In addition,
highinvestments were made in the development of new excipient variants to
advance the product portfolio. Furthermore, the key players are involved in
collaborations, mergers, and R&D activities that propel market growth.
Europe embraces the second-largest position in the
biopharmaceutical excipients market due to growing investments in the
pharmaceutical sector and increasing production capacity across the region. In
addition, the region experienced high demands for pharmaceutical products.
Moreover, countries such asGermany, Italy, the UK, France, and Spain have
invested huge amounts in the manufacturing of new vaccines.
Asia-Pacific is anticipated to be the fastest-growing
regional market over the projected timeline due to the rising investment in
pharmaceutical research and production facilities, increasing consumption of
medicines, and supportive government alliances and subsidy schemes. In
addition, the availability of highly skilled research employees and an
economical workforce is creating opportunities for the industry players.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Overview
Tissues, cell lines, and cells are tested,
characterized, stored, and collected by the cell banking outsourcing industry.
These activities are carried out to aid in the production of biopharmaceuticals
as well as research and development activities, ensuring minimal side effects
and great efficacy. The technique for cell preservation entails initially
proliferating cells, which subsequently multiply into a large number of
identical cells, which are then stored in cryovials for future use. The
production of regenerative medicine is essentially based on the use of cells.
During the projection period of 2021 to 2027, the cell
banking outsourcing market share is estimated to reach USD 9476.9 million,
growing at a CAGR of 15.6%.
Market Trends
During the forecast period, the cell
banking outsourcing market is expected to rise due to an increase in the number
of cell banks around the world. Another factor projected to drive market growth
is the growing number of applications of cell-based products for research and
therapeutics. Furthermore, a jump in the number of start-ups focusing on
cell-based therapeutics and vaccine production is expected to drive market
expansion. Similarly, the growing emphasis on regenerative and customized
medicine is expected to fuel growth in the cell banking outsourcing industry.
Due to well-established healthcare infrastructure, large patient populations, and
significant healthcare expenditures, several key businesses focus on tailoring
products and services to the American and European markets. There are no public
cord blood banks in Africa, and importing cord blood units from other countries
is prohibitively expensive for most patients. With first-to-market advantage,
launching subsidiaries in developing regions can be advantageous.
Furthermore, as the prevalence of
oncology-related diseases and other infectious chronic diseases rises,
cytological R&D, in which cell banking plays a key role, is predicted to
develop. Over the projected period, R&D for commercialization of novel
characterisation and cryopreservation procedures is expected to significantly
boost profitable business potential.
Concerns over sharing of crucial clinical
information discovered during the donor screening process, as well as issues
around the techniques used to get informed permission from potential cord blood
donors, are limiting the expansion of the cell banking outsourcing business.
Competitive Dynamics
The notable players of the market are
CordLife (Singapore), Cleancells (France), Charles River Laboratories (US), BSL
Bioservice (Germany), BioReliance (US), Sartorius (Germany), Covance (US),
LifeCell International Pvt. Ltd. (India), Goodwin Biotechnology Inc. (US),
GlobalStem Inc. (US), Cryo-Cell International Inc. (US), Lonza (Switzerland),
PX’TherapeuticsSA (France), Wuxi Apptec (China), and the SGS Life Sciences
(Switzerland).
Segmental Analysis
The global cell
banking outsourcing market outlook is divided into three categories: bank,
cell, and application.
The market has been classified into three
categories based on bank type: master cell banking, working cell banking, and
viral cell banking. Because of its widespread utility, master cell banking is
expected to have the largest market share in the worldwide cell banking
outsourcing market.
The cell banking outsourcing market has
been divided into stem cell banking and non-stem cell banking based on cell
type. Because of its growing uses in regenerative medicine, the stem cell
banking sector is expected to have the greatest market share in 2021.
Cell bank storage, cell bank preparation,
and bank characterization and testing are the application segments of the cell
banking outsourcing market.
Regional Overview
North America, Europe, Asia-Pacific, and
the rest of the globe are the regions that make up the market.
Because of the greater adoption rates of
novel technologies for the manufacturing of vaccines and therapeutic
antibodies, North America is expected to have the greatest market share in
2021. Furthermore, the presence of various biopharmaceutical businesses in the
region is expected to drive the cell banking outsourcing market in North
America to new heights in the near future. North America is also likely to be a
lucrative market due to the large number of research and development
initiatives related to cytological inquiry for proteomics, genomics, and
medication and vaccine development currently underway in the region. The
growing demand for vaccines and biopharmaceuticals is expected to boost this
region's growth.
The growing prevalence of leukemia in
European countries is likely to drive the region's cell banking outsourcing
industry forward. Furthermore, the region's cell banking outsourcing market is
benefiting from an increase in the number of clinical trials and associations
dedicated to discovering a cure for incurable diseases.
The cell banking outsourcing market in
Asia-Pacific is predicted to develop at the quickest rate because to the
increased prevalence of hematological illnesses, the growth of healthcare
facilities, and growing support for the use of stem cell-based therapies.
Furthermore, the expansion is likely to be fueled by an increase in the number
of favorable government initiatives relating to biotechnology investments. In
addition, continuous research and development for cancer therapy and fertility
preservation helps to fuel demand for cell banking services.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Overview
Cellulite
production has swelled in recent years due to poor nourishment, static
postures, dehydration, inflammation, eating habits, alcohol intake, among other
factors. The MRFR Cellulite
Treatment Market Sizereport
predicts that the market will earn a revenue level of USD 1,086.44 million
at a CAGR of 8.97% by 2027.
Most
corporate employees with cellulite are working on their wellbeing and fitness
to amplify their productivity. Resultantly, many firms are partnering with
clinics and hospitals to help their staff stay healthy.The cellulite treatment market is
motivated by the tremendous influx of female population in metro centers due to
employment as younger employees are more health-conscious and press for a
better physique to avoid medical problems.
The foremost players in the cellulite
treatment market areNubway (China), Zimmer
Aesthetics (Germany), Skinrex Co., Ltd. (South Korea), Cymedics (Germany),
Tanceuticals, LLC. (US), Cynosure, Inc. (US), Inceler Medikal Co. Ltd.
(Turkey), Syneron Medical Inc (US), Hologic Inc. (US), Cutera (US), Beijing
Sincoheren S & T Development Co., Ltd, (China), Candela Medical (US), and
Merz Pharma GmbH & Co. KGaA (Germany).
Segmental
Analysis
The
segmentation of the cellulite treatment market Insightshas been conducted based on cellulite type,
treatment procedure, region, and end use. The cellulite treatment market is
divided into three segments based on end use: specialized dermatological
clinics, hospitals, and ambulatory surgical centers. The cellulite treatment market has been
segmented based on treatment procedures into minimally invasive, non-invasive,
and topical treatment. The cellulite treatment market has been divided into
three segments based on cellulite type: soft cellulite, hard cellulite, san
francisco cellulite treatment and edematous cellulite. The region segment of
the cellulite treatment market includes North America, Asia-Pacific, Europe, and other important regions.
Detailed
Regional Analysis
The
regional assessment of the cellulite treatment market includesNorth America,
Asia-Pacific, Europe, and other important regions. North America will have the
greatest cellulite treatment market share in 2020, owing to well-established
product development research groups, the availability of novel treatment
products, the consumption of unhealthy diets, and the significant desire for
the sculpted figure. The primary players are expanding their operational
facilities across the region, collaborating in collaborations and partnerships,
and launching new products to drive economic interests. Due to the
transformation of healthcare infrastructure, the construction of R&D
facilities, and increased awareness about body contouring and physical
wellness, the Asia-Pacific cellulite treatment market is estimated to be the
fastest regional market.
Competitive
Analysis
The continuation of occasional lockdowns in
numerous regions may cause the market expansion to be hampered if resources
such as labor and supply chains are severely impacted. The global market is
expected to diversify in operational techniques as innovative models for
operation and delivery are implemented. Government assistance is expected to
support worldwide market development in the next years. Due to the return of
COVID cases in many locations, the market may exhibit constrained growth. It is
projected that the emphasis on accumulating reserves of resources to deal with
unexpected crises would impact future market trends. Market developments and
research are expected to generate attractive growth opportunities in the next
years. The reliance on online commerce for sales is expected to increase
significantly during the forecast period, prompting market stakeholders to
invest more in its growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.